Syapse
Syapse Raises $35M in Venture Capital Funding
The precision oncology software company will continue to expand its network of partners to improve outcomes for cancer patients in community healthcare settings.
Illumina, Syapse Partner on Study of Comprehensive Genomic Profiling in Advanced Cancer
Syapse will analyze data from single-gene, small panel, and comprehensive genomic profiling tests in the community oncology setting, with input from Illumina.
Real-World Data Points to Racial Disparity in BRCA1/2 Testing Among TNBC Patients
Researchers analyzed data from Syapse's Learning Health Network and found that more Black patients were unable to be tested or declined it compared to white patients.
With nearly $100 million in new investments since last year, the San Francisco-based informatics firm looks to ramp up its precision oncology partnerships.
Syapse Raises $68M in Equity Financing
The San Francisco-based precision oncology informatics company now has landed $166 million in equity investment since its inception in 2014.